Formulation and Profile of FMX101 4% Minocycline Topical Foam for the Treatment of Acne Vulgaris April 1, 2020 J Clin Aesthet Dermatol. 2020;13(4):14–21 by Leon Kircik, MD; James Q Del CONTINUE READING »
